Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and has an
overall five-year survival rate of less than twenty percent. For patients with unresectable …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. It is
principally associated with liver cirrhosis and chronic liver disease. The major risk factors for …

Aim To report the multicenter retrospective experience on combination of balloon-occluded
MWA (b-MWA) followed by balloon-occluded TACE (b-TACE) in patients with liver …

Objectives To compare the safety and efficacy of balloon-occluded transarterial
chemoembolization (B-TACE) and conventional TACE (C-TACE) in treating single …

BACKGROUND Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide
and the second leading cause of cancer-related deaths. Transcatheter arterial …

In 2013 and 2014, the development of microcatheters with balloons for the 4‐Fr system and
new embolization materials provided various options for transarterial chemoembolization …

Purpose To evaluate the potential differences in non-target embolization and vessel
microsphere filling of a reflux-control microcatheter (RCM) compared to a standard end-hole …

Background: Microballoon interventions (MBIs) have been proposed as useful tools to
improve the efficacy of locoregional liver treatments. The aim of this systematic review was to …

Simple Summary Tumors originating in the liver and biliary system remain a significant
health concern globally. The majority are cancers originating in liver cells known as …

Simple Summary Hepatocellular carcinoma (HCC) is a growing healthcare problem, with
most of the cases occurring in patients with an underlying chronic liver disease. Transarterial …